Revance Therapeutics Inc. sell ReynadJ
Start price
10.12.24
/
0%
€2.90
Target price
10.12.25
-
Performance (%)
21.38%
End price
11.12.25
-
Summary
This prediction is currently being closed. The prediction currently has a disappointing performance of 21.38%. This prediction was marked as speculative and is excluded from ReynadJ's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to ReynadJ what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Little innovation
Few uniques
Growths slower than the competition
Bad culture
Comments by ReynadJ for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Sell Revance Therapeutics Inc.
In the thread Trading Revance Therapeutics Inc.
Die von ReynadJ gewählte maximale Laufzeit wurde überschritten